Case number 2023-2434
Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 24, 2024 | 64 | The following additional conflict date submitted by Dov Philip Grossman for Bayer Pharma Aktiengesellschaft has been accepted by the court: 10/11/2024. [1012767] [MJL] [Entered: 06/24/2024 11:10 AM] (0) |
| Jun 24, 2024 | 63 | Notice from Appellant Bayer Pharma Aktiengesellschaft regarding conflicts with oral argument. Service: 06/24/2024 by email. [1012749] [23-2434] [Dov Grossman] [Entered: 06/24/2024 10:28 AM] (4) |
| Jun 13, 2024 | 61 | The following conflict dates submitted by Dov Philip Grossman for Bayer Pharma Aktiengesellschaft have been accepted by the court: 08/05/2024, 08/06/2024, 08/07/2024, 08/08/2024, 08/09/2024. [1010903] [MJL] [Entered: 06/13/2024 01:38 PM] (0) |
| Jun 13, 2024 | 60 | Notice from Appellant Bayer Pharma Aktiengesellschaft regarding conflicts with oral argument. Service: 06/13/2024 by email. [1010863] [23-2434] [Dov Grossman] [Entered: 06/13/2024 12:08 PM] (4) |
| Jun 12, 2024 | 62 | 6 paper copies of Doc. No. [38] received from Appellees InvaGen Pharmaceuticals Inc., Mylan Pharmaceuticals Inc. and Teva Pharmaceuticals USA, Inc.. [1010962] [VDW] [Entered: 06/13/2024 03:44 PM] (0) |
| Jun 11, 2024 | 58 | Notice from Appellee InvaGen Pharmaceuticals Inc. regarding conflicts with oral argument. Service: 06/11/2024 by email. [1010350] [23-2434] [A. Neal Seth] [Entered: 06/11/2024 04:12 PM] (2) |
| Jun 11, 2024 | 57 | The following conflict dates submitted by Wendy L. Devine for Mylan Pharmaceuticals Inc. have been accepted by the court: 10/07/2024, 10/08/2024, 10/09/2024, 10/10/2024, 10/11/2024. [1010329] [MJL] [Entered: 06/11/2024 03:39 PM] (0) |
| Jun 11, 2024 | 56 | Notice from Appellee Mylan Pharmaceuticals Inc. regarding conflicts with oral argument. Service: 06/11/2024 by email. [1010276] [23-2434] [Wendy Devine] [Entered: 06/11/2024 02:38 PM] (5) |
| Jun 10, 2024 | 59 | 6 paper copies of Doc. No. [52], [51], [33] received from Appellant Bayer Pharma Aktiengesellschaft. [1010474] [VDW] [Entered: 06/12/2024 09:56 AM] (0) |
| Jun 10, 2024 | 55 | Notice from Appellee Teva Pharmaceuticals USA, Inc. regarding conflicts with oral argument. Service: 06/10/2024 by email. [1009897] [23-2434] [John Rozendaal] [Entered: 06/10/2024 12:38 PM] (2) |
| Jun 6, 2024 | 54 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [1009433] [GWK] [Entered: 06/06/2024 03:26 PM] (1) |
| Jun 6, 2024 | 53 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [1009432] [GWK] [Entered: 06/06/2024 03:25 PM] (0) |
| May 31, 2024 | 52 | MODIFIED ENTRY: APPENDIX FILED by Appellant Bayer Pharma Aktiengesellschaft. Service: 05/31/2024 by email. [1007891] --[Edited 06/06/2024 by GWK - compliance review complete] [Dov Grossman] [Entered: 05/31/2024 02:00 PM] (504) |
| May 24, 2024 | 51 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Bayer Pharma Aktiengesellschaft. Service: 05/24/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [1006603] --[Edited 06/04/2024 by GWK - compliance review complete] [Dov Grossman] [Entered: 05/24/2024 05:21 PM] (38) |
| May 24, 2024 | 50 | Notice of Related Case Information for Appellant Bayer Pharma Aktiengesellschaft. Service: 05/24/2024 by email. [1006601] [23-2434] [Dov Grossman] [Entered: 05/24/2024 05:19 PM] (9) |
| May 24, 2024 | 49 | Amended Certificate of Interest for Appellant Bayer Pharma Aktiengesellschaft. Service: 05/24/2024 by email. [1006600] [23-2434] [Dov Grossman] [Entered: 05/24/2024 05:18 PM] (3) |
| May 24, 2024 | 48 | Amended Entry of Appearance for Dov P. Grossman; Richard Hildreth III; Alexander S. Zolan; Ben Picozzi as counsel for Appellant Bayer Pharma Aktiengesellschaft. Service: 05/24/2024 by email. [1006599] [23-2434] [Dov Grossman] [Entered: 05/24/2024 05:14 PM] (2) |
| Apr 18, 2024 | 47 | ORDER granting the motion [46] to the extent that ECF No. 38 is accepted for filing as appellees' response brief and ECF No. 40 is not accepted for filing. Service as of this date by the Clerk of Court. [998344] [LMS] [Entered: 04/18/2024 08:35 AM] (2) |
| Apr 11, 2024 | 46 | MOTION of Appellees Teva Pharmaceuticals USA, Inc. and InvaGen Pharmaceuticals Inc. to extend the time to 04/03/2024 to file brief. Service: 04/11/2024 by email. [996895] [23-2434] [John Rozendaal] [Entered: 04/11/2024 04:26 PM] (115) |
| Apr 10, 2024 | 45 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Appellant's motion [41] does not include a Certificate of Interest. CORRECTION: For future relevant filings, please include a certificate of interest as required by FCR 47.4(b). THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [996471] [GWK] [Entered: 04/10/2024 12:16 PM] (0) |
| Apr 10, 2024 | 44 | **TEXT ONLY** ORDER granting motion to extend time to file brief [41] filed by Appellant Bayer Pharma Aktiengesellschaft. The reply brief is due 05/24/2024. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [996469] [GWK] [Entered: 04/10/2024 12:14 PM] (0) |
| Apr 9, 2024 | 43 | Notice of Related Case Information for Appellant Bayer Pharma Aktiengesellschaft. Service: 04/09/2024 by email. [996249] [23-2434] [Dov Grossman] [Entered: 04/09/2024 05:07 PM] (9) |
| Apr 9, 2024 | 42 | Amended Certificate of Interest for Appellant Bayer Pharma Aktiengesellschaft. Service: 04/09/2024 by email. [996245] [23-2434] [Dov Grossman] [Entered: 04/09/2024 05:05 PM] (3) |
| Apr 9, 2024 | 41 | MOTION of Appellant Bayer Pharma Aktiengesellschaft to extend the time to 05/24/2024 to file brief. Service: 04/09/2024 by email. [996240] [23-2434] [Dov Grossman] [Entered: 04/09/2024 05:03 PM] (7) |
| Apr 9, 2024 | 40 | CORRECTED RESPONSE BRIEF FILED by Appellee Mylan Pharmaceuticals Inc.. Service: 04/09/2024 by email. [996163] [23-2434] This document is not accepted for filing. See 04/18/2024 order at [47]. [Wendy Devine] [Entered: 04/09/2024 03:42 PM] (76) |
| Apr 8, 2024 | 39 | NOTICE OF NON-COMPLIANCE: The submission of Appellees InvaGen Pharmaceuticals Inc., Mylan Pharmaceuticals Inc. and Teva Pharmaceuticals USA, Inc., Response Brief [38], is not in compliance with the rules of this court (see attached). Compliant document due on 04/15/2024. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [995816] [GWK] [Entered: 04/08/2024 04:19 PM] (2) |
| Apr 3, 2024 | 38 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellees InvaGen Pharmaceuticals Inc., Mylan Pharmaceuticals Inc. and Teva Pharmaceuticals USA, Inc.. Service: 04/03/2024 by email. [995038] --[Edited 04/18/2024 by GWK]. This document has been accepted for filing. See 04/18/2024 order at [47]. [Wendy Devine] [Entered: 04/03/2024 06:26 PM] (82) |
| Mar 5, 2024 | 37 | Entry of Appearance for Tasha M. Thomas as counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 03/05/2024 by email. [988527] [23-2434] [Richard Torczon] [Entered: 03/05/2024 05:36 PM] (1) |
| Mar 5, 2024 | 36 | Mylan Pharmaceuticals Inc.'s Notice of Susannah Gagnon's Withdrawal as Non-Principal Counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 03/05/2024 by email. [988524] [23-2434] [Richard Torczon] [Entered: 03/05/2024 05:26 PM] (3) |
| Feb 7, 2024 | 35 | **TEXT ONLY** ORDER granting motion to extend time to file brief [34] filed by Appellee Mylan Pharmaceuticals Inc. The response brief is due 04/03/2024. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [982147] [GWK] [Entered: 02/07/2024 10:36 AM] (0) |
| Feb 6, 2024 | 34 | MOTION of Appellee Mylan Pharmaceuticals Inc. to extend the time to 04/03/2024 to file brief. Service: 02/06/2024 by email. [982048] [23-2434] [Richard Torczon] [Entered: 02/06/2024 05:08 PM] (8) |
| Jan 22, 2024 | 32 | Notice of Related Case Information for Appellant Bayer Pharma Aktiengesellschaft. Service: 01/22/2024 by email. [978258] [23-2434] [Dov Grossman] [Entered: 01/22/2024 04:00 PM] (9) |
| Jan 22, 2024 | 33 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellant Bayer Pharma Aktiengesellschaft. Service: 01/22/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [978262] --[Edited 01/30/2024 by GWK - compliance review complete] [Dov Grossman] [Entered: 01/22/2024 04:02 PM] (145) |
| Jan 22, 2024 | 31 | Amended Certificate of Interest for Appellant Bayer Pharma Aktiengesellschaft. Service: 01/22/2024 by email. [978254] [23-2434] [Dov Grossman] [Entered: 01/22/2024 03:57 PM] (3) |
| Dec 27, 2023 | 30 | Notice from Appellee Mylan Pharmaceuticals Inc. Mylan Pharmaceuticals Inc.'s Withdrawal of Elham Firouzi Steiner as Counsel. Service: 12/27/2023 by email. [973167] [23-2434] [Wendy Devine] [Entered: 12/27/2023 03:14 PM] (6) |
| Dec 6, 2023 | 29 | **TEXT ONLY** ORDER granting motion to extend time to file brief [27] filed by Appellant Bayer Pharma Aktiengesellschaft. The opening brief is due 01/22/2024. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [968029] [GWK] [Entered: 12/06/2023 11:09 AM] (0) |
| Dec 5, 2023 | 28 | Notice of Related Case Information for Appellant Bayer Pharma Aktiengesellschaft. Service: 12/05/2023 by email. [967887] [23-2434]--[Edited 12/06/2023 by GWK] [Dov Grossman] [Entered: 12/05/2023 04:59 PM] (8) |
| Dec 5, 2023 | 27 | MOTION of Appellant Bayer Pharma Aktiengesellschaft to extend the time to 01/22/2024 to file brief. Service: 12/05/2023 by email. [967884] [23-2434] [Dov Grossman] [Entered: 12/05/2023 04:51 PM] (8) |
| Nov 7, 2023 | 26 | Certified list received. Service: 11/07/2023 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [962046] [JSP] [Entered: 11/07/2023 03:46 PM] (48) |
| Oct 13, 2023 | 25 | Corrected Entry of Appearance for Teresa Summers as counsel for Appellee InvaGen Pharmaceuticals Inc.. Service: 10/13/2023 by email. [956376] [23-2434] [Teresa Summers] [Entered: 10/13/2023 05:15 PM] (1) |
| Oct 13, 2023 | 24 | Corrected Entry of Appearance for Dov P. Grossman; Richard Hildreth III; Alexander S. Zolan as counsel for Appellant Bayer Pharma Aktiengesellschaft. Service: 10/13/2023 by email. [956332] [23-2434] [Dov Grossman] [Entered: 10/13/2023 04:14 PM] (2) |
| Oct 13, 2023 | 23 | Corrected Entry of Appearance for John Christopher Rozendaal; Chandrika Vira as counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 10/13/2023 by email. [956324] [23-2434] [John Rozendaal] [Entered: 10/13/2023 04:03 PM] (1) |
| Oct 13, 2023 | 22 | NOTICE OF NON-COMPLIANCE: The submission of Appellee InvaGen Pharmaceuticals Inc., Entry of Appearance [10], is not in compliance with the rules of this court (see attached). Compliant document due on 10/20/2023. Service as of this date by the Clerk of Court. [956228] [GWK] [Entered: 10/13/2023 12:34 PM] (2) |
| Oct 13, 2023 | 21 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Bayer Pharma Aktiengesellschaft, Entry of Appearance [16], is not in compliance with the rules of this court (see attached). Compliant document due on 10/20/2023. Service as of this date by the Clerk of Court. [956225] [GWK] [Entered: 10/13/2023 12:23 PM] (2) |
| Oct 12, 2023 | 20 | Corrected Entry of Appearance for Wendy L. Devine; Richard Torczon; Elham F. Steiner; Kelsey J. Curtis; Susannah Gagnon; Matthew Greinert as counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 10/12/2023 by email. [956051] [23-2434]--[Edited 10/13/2023 by GWK to add text-searchable document] [Wendy Devine] [Entered: 10/12/2023 05:41 PM] (2) |
| Oct 12, 2023 | 19 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Teva Pharmaceuticals USA, Inc., Entry of Appearance [6], is not in compliance with the rules of this court (see attached). Compliant document due on 10/19/2023. Service as of this date by the Clerk of Court. [956041] [GWK] [Entered: 10/12/2023 04:50 PM] (2) |
| Oct 12, 2023 | 18 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Mylan Pharmaceuticals Inc., Entry of Appearance [2], is not in compliance with the rules of this court (see attached). Compliant document due on 10/19/2023. Service as of this date by the Clerk of Court. [956030] [GWK] [Entered: 10/12/2023 04:30 PM] (2) |
| Oct 12, 2023 | 17 | Notice of Related Case Information for Appellant Bayer Pharma Aktiengesellschaft. Service: 10/12/2023 by email. [956027] [23-2434] [Dov Grossman] [Entered: 10/12/2023 04:28 PM] (8) |
| Oct 12, 2023 | 16 | Entry of Appearance for Dov P. Grossman; Richard Hildreth III as counsel for Appellant Bayer Pharma Aktiengesellschaft. Service: 10/12/2023 by email. [956025] [23-2434] This document is non-compliant. See Doc No. [21] [Dov Grossman] [Entered: 10/12/2023 04:26 PM] (1) |
| Oct 12, 2023 | 15 | Docketing Statement for the Appellant Bayer Pharma Aktiengesellschaft. Service: 10/12/2023 by email. [956019] [23-2434] [Dov Grossman] [Entered: 10/12/2023 04:25 PM] (3) |
| Oct 12, 2023 | 14 | Certificate of Interest for Appellant Bayer Pharma Aktiengesellschaft. Service: 10/12/2023 by email. [956016] [23-2434] [Dov Grossman] [Entered: 10/12/2023 04:24 PM] (3) |
| Oct 12, 2023 | 13 | Docketing Statement for the Appellee InvaGen Pharmaceuticals Inc.. Service: 10/12/2023 by email. [955931] [23-2434] [A. Neal Seth] [Entered: 10/12/2023 01:37 PM] (2) |
| Oct 12, 2023 | 12 | Notice of Related Case Information for Appellee InvaGen Pharmaceuticals Inc.. Service: 10/12/2023 by email. [955928] [23-2434] [A. Neal Seth] [Entered: 10/12/2023 01:36 PM] (4) |
| Oct 12, 2023 | 11 | Certificate of Interest for Appellee InvaGen Pharmaceuticals Inc.. Service: 10/12/2023 by email. [955927] [23-2434] [A. Neal Seth] [Entered: 10/12/2023 01:34 PM] (3) |
| Oct 12, 2023 | 10 | Entry of Appearance for Neal Seth; Teresa Summers as counsel for Appellee InvaGen Pharmaceuticals Inc.. Service: 10/12/2023 by email. [955925] [23-2434] This document is non-compliant. See Doc No. [22] [A. Neal Seth] [Entered: 10/12/2023 01:32 PM] (1) |
| Oct 12, 2023 | 9 | Docketing Statement for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 10/12/2023 by email. [955886] [23-2434] [John Rozendaal] [Entered: 10/12/2023 12:06 PM] (2) |
| Oct 12, 2023 | 8 | Notice of Related Case Information for Appellee Teva Pharmaceuticals USA, Inc.. Service: 10/12/2023 by email. [955885] [23-2434] [John Rozendaal] [Entered: 10/12/2023 12:05 PM] (8) |
| Oct 12, 2023 | 7 | Certificate of Interest for Appellee Teva Pharmaceuticals USA, Inc.. Service: 10/12/2023 by email. [955884] [23-2434] [John Rozendaal] [Entered: 10/12/2023 12:04 PM] (3) |
| Oct 12, 2023 | 6 | Entry of Appearance for John Christopher Rozendaal; Chandrika Vira as counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 10/12/2023 by email. [955882] [23-2434] This document is non-compliant. See Doc No. [19] [John Rozendaal] [Entered: 10/12/2023 12:02 PM] (1) |
| Oct 11, 2023 | 5 | Docketing Statement for the Appellee Mylan Pharmaceuticals Inc.. Service: 10/11/2023 by email. [955709] [23-2434] [Wendy Devine] [Entered: 10/11/2023 05:15 PM] (2) |
| Oct 11, 2023 | 4 | Notice of Related Case Information for Appellee Mylan Pharmaceuticals Inc.. Service: 10/11/2023 by email. [955708] [23-2434] [Wendy Devine] [Entered: 10/11/2023 05:14 PM] (3) |
| Oct 11, 2023 | 3 | Certificate of Interest for Appellee Mylan Pharmaceuticals Inc.. Service: 10/11/2023 by email. [955707] [23-2434] [Wendy Devine] [Entered: 10/11/2023 05:12 PM] (3) |
| Oct 11, 2023 | 2 | Entry of Appearance for Wendy L. Devine; Richard Torczon; Elham F. Steiner; Kelsey J. Curtis; Susannah Gagnon; Matthew Greinert as counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 10/11/2023 by email. [955706] [23-2434] This document is non-compliant. See Doc No. [18] [Wendy Devine] [Entered: 10/11/2023 05:10 PM] (2) |
| Sep 28, 2023 | 1 | Appeal docketed. Received: 09/22/2023. [953041] Entry of Appearance is due on 10/12/2023. Certificate of Interest is due on 10/12/2023. Docketing Statement is due on 10/12/2023. Certified List is due on 11/07/2023. [ALK] [Entered: 09/28/2023 10:35 AM] (0) |
